BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37338339)

  • 41. Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
    Purroy N; Bergua J; Gallur L; Prieto J; Lopez LA; Sancho JM; García-Marco JA; Castellví J; Montes-Moreno S; Batlle A; de Villambrosia SG; Carnicero F; Ferrando-Lamana L; Piris MA; Lopez A
    Br J Haematol; 2015 Apr; 169(2):188-98. PubMed ID: 25521006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era.
    Liang X; Hu R; Li Q; Wang C; Liu Y
    Exp Hematol; 2023 Jun; 122():1-9. PubMed ID: 36933759
    [No Abstract]   [Full Text] [Related]  

  • 43. Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
    Kimani S; Painschab MS; Kaimila B; Kasonkanji E; Zuze T; Tomoka T; Mulenga M; Nyasosela R; Chikasema M; Mtangwanika A; Chawinga M; Mhango W; Nicholas S; Chimzimu F; Kampani C; Krysiak R; Lilly A; Randall C; Seguin R; Westmoreland KD; Montgomery ND; Fedoriw Y; Gopal S
    Lancet Glob Health; 2021 Jul; 9(7):e1008-e1016. PubMed ID: 34022150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study.
    Lugtenburg P; Avivi I; Berenschot H; Ilhan O; Marolleau JP; Nagler A; Rueda A; Tani M; Turgut M; Osborne S; Smith R; Pfreundschuh M
    Haematologica; 2017 Nov; 102(11):1913-1922. PubMed ID: 28935843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
    George A; Tam CS; Seymour JF
    Leuk Lymphoma; 2013 Dec; 54(12):2575-6. PubMed ID: 23597141
    [No Abstract]   [Full Text] [Related]  

  • 47. Primary cutaneous diffuse large B cell lymphoma, leg type.
    Dongre A; Kar S; Gondse S; Gangane N; Mehra BK
    Indian J Dermatol Venereol Leprol; 2011; 77(2):212-4. PubMed ID: 21393962
    [No Abstract]   [Full Text] [Related]  

  • 48. Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement.
    Kojima M; Amaki J; Ogiya D; Ando K; Nakamura N
    J Clin Exp Hematop; 2020 Jun; 60(2):60-61. PubMed ID: 32404573
    [No Abstract]   [Full Text] [Related]  

  • 49. Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
    Oki Y; Ewer MS; Lenihan DJ; Fisch MJ; Hagemeister FB; Fanale M; Romaguera J; Pro B; Fowler N; Younes A; Astrow AB; Huang X; Kwak LW; Samaniego F; McLaughlin P; Neelapu SS; Wang M; Fayad LE; Durand JB; Rodriguez MA
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):152-8. PubMed ID: 25445468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
    Choi WW; Weisenburger DD; Greiner TC; Piris MA; Banham AH; Delabie J; Braziel RM; Geng H; Iqbal J; Lenz G; Vose JM; Hans CP; Fu K; Smith LM; Li M; Liu Z; Gascoyne RD; Rosenwald A; Ott G; Rimsza LM; Campo E; Jaffe ES; Jaye DL; Staudt LM; Chan WC
    Clin Cancer Res; 2009 Sep; 15(17):5494-502. PubMed ID: 19706817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful multidisciplinary management of an asymptomatic gastrosplenic fistula in a diffuse large B cell lymphoma patient.
    Mansouri S; Assane C; Malo FC
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35256358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment with doxorubicin-based protocol in cardiac involvement diffuse large B-cell lymphoma: A case report.
    Tekinalp A; Kars TU; Dikici HZ; Yılmaz PD; Demircioğlu S; Çeneli Ö
    J Oncol Pharm Pract; 2022 Mar; 28(2):449-452. PubMed ID: 34549658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary breast lymphoma - a case report.
    Rajabto W; Angkasa YK; Harahap AS; Ham MF; Brahma B
    Klin Onkol; 2021; 34(6):477-480. PubMed ID: 34911334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Go SI; Park MJ; Song HN; Kim HG; Kang MH; Lee HR; Kim Y; Kim RB; Lee SI; Lee GW
    J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):567-576. PubMed ID: 27104110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary Lymphoma of Liver-a Rare Space-Occupying Lesion.
    Patkar S; Dutt K; Shah A; Sengar M; Goel M
    J Gastrointest Cancer; 2020 Sep; 51(3):1057-1060. PubMed ID: 32333249
    [No Abstract]   [Full Text] [Related]  

  • 56. Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma.
    Kilani Y; Sohail H; Lim CY; Payette A; Kamal SAF; Afzal A; Khan T; Paracha N; Muppidi MR; Sittler D
    Am J Case Rep; 2022 Sep; 23():e937500. PubMed ID: 36151707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Febrile cellulitis surrounding a scar revealing a large immunoblastic B-cell lymphoma].
    Charavin-Cocuzza M; Templier I; Simon A; Salameire D; Cuchet E; Reymond JL; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2008 Dec; 135(12):848-51. PubMed ID: 19084696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary B cell lymphoma of the tongue base: a case report.
    Bechir A; Asma A; Haifa R; Nesrine A; Yosra BY; Badreddine S; Abderrahim K
    Pan Afr Med J; 2016; 25():174. PubMed ID: 28292136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva.
    Harada N; Tagami M; Koh H; Ohsawa M; Hino M; Nakamae H
    Int J Hematol; 2021 Oct; 114(4):413-414. PubMed ID: 34424492
    [No Abstract]   [Full Text] [Related]  

  • 60. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
    Wang L; Wang W; Li X; Guo Y; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):307-12. PubMed ID: 25030862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.